Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Patent licensing fees	$ 2,050,000	$ 5,488,088
Revenues total	2,050,000	5,488,088
Cost of revenues:
Litigation and licensing expenses	1,314,928	4,692,969
Selling, general and administrative expenses	3,848,611	1,513,822
Total operating expenses	5,163,539	6,206,791
Loss from operations	(3,113,539)	(718,703)
Gain on forgiveness of debt	1,850,018
Gain on settlement of accounts payable and accrued expenses	1,725,965
Warrant expense	(1,154,905)
Change in fair market value of warrant liability	(481,282)	275,000
Change in fair market value of derivative liability		275,000
Loss on conversion of debt	(305,556)
Loss on debt extinguishment	(730,378)
Loss on impairment of assets	(1,651,614)
Other Income		1,000
Interest expense	(291,702)	(804,456)
Total other expense	(1,039,454)	(528,456)
Net loss before income tax	(4,152,993)	(1,247,159)
Provision for income taxes	(1,806)	(65,363)
Net loss	(4,154,799)	(1,312,522)
Net income attributable to non-controlling interest in subsidiary		11
Net Loss Attributable to Quest Patent Research Corporation	$ (4,154,799)	$ (1,312,511)
Net loss per share – Basic and Diluted (in Dollars per share)	$ (0.01)	$ 0
Weighted average shares outstanding – basic (in Shares)	511,863,731	383,038,334
Weighted average shares outstanding - diluted (in Shares)	613,878,234	383,038,334